Alnylam Pharmaceuticals Inc (ALNY)
NASDAQ · Healthcare
Alnylam Pharmaceuticals Inc Net Income 2008–2025
Alnylam Pharmaceuticals Inc annual/quarterly net income history and growth rate from 2008 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Alnylam Pharmaceuticals Inc net income for the quarter ending September 30, 2025 was 251.1 M, a 325.05% decrease year-over-year.
- Alnylam Pharmaceuticals Inc net income for the twelve months ending September 30, 2025 was 15.8 M, a 107.46% decrease year-over-year.
- Alnylam Pharmaceuticals Inc annual net income for 2025 was 313.7 M, a 212.79% decrease from 2024.
- Alnylam Pharmaceuticals Inc annual net income for 2024 was -278.2 M, a 36.82% decrease from 2023.
- Alnylam Pharmaceuticals Inc annual net income for 2023 was -440.2 M, a 61.08% decrease from 2022.
- Alnylam Pharmaceuticals Inc annual net income for 2022 was -1.1 B.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alnylam Pharmaceuticals Inc Net Income — FAQ
Alnylam Pharmaceuticals Inc (ALNY) net income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Alnylam Pharmaceuticals Inc's net income?
Alnylam Pharmaceuticals Inc (ALNY) reported net income of $314M for fiscal 2025.
Where can I see ALNY's net income history?
The chart and table above show Alnylam Pharmaceuticals Inc's net income by year and by quarter, including the growth rate.